The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Speakers' Bureau - ARIAD; Bristol-Myers Squibb; Novartis
Research Funding - Novartis
Treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) treated with second-line nilotinib (NIL): First results from the ENESTop study.
 
Timothy P Hughes
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis
Research Funding - ARIAD; Bristol-Myers Squibb; Novartis
 
Carla Boquimpani
No Relationships to Disclose
 
Dong-Wook Kim
Honoraria - Bristol-Myers Squibb; Novartis; ZYLANG
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer; ZYLANG
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Pfizer; ZYLANG
Research Funding - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer; ZYLANG
 
Noam Benyamini
No Relationships to Disclose
 
Nelma Cristina D. Clementino
No Relationships to Disclose
 
Vasily Shuvaev
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Sikander Ailawadhi
Consulting or Advisory Role - Amgen; Takeda
Travel, Accommodations, Expenses - Amgen; Takeda
 
Jeffrey Howard Lipton
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
 
Anna G. Turkina
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Novartis
Research Funding - Bristol-Myers Squibb; Novartis; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Raquel De Paz Arias
No Relationships to Disclose
 
Beatriz Moiraghi
Speakers' Bureau - Bristol-Myers Squibb; Novartis
 
Franck E. Nicolini
No Relationships to Disclose
 
Jolanta Dengler
Travel, Accommodations, Expenses - Amgen; Novartis; Roche
 
Tomasz Sacha
Employment - Optegra
Honoraria - Optegra
Consulting or Advisory Role - Acraf; Bristol-Myers Squibb; Novartis
Speakers' Bureau - Acraf; Bristol-Myers Squibb; Novartis
Expert Testimony - Acraf; Bristol-Myers Squibb; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Naoto Takahashi
Consulting or Advisory Role - Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Novartis
 
Rafik Fellague-Chebra
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Honoraria - Novartis
Research Funding - Novartis
Other Relationship - Novartis
 
Sandip Acharya
Employment - Novartis
 
Stephane Wong
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Yu Jin
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Francois-Xavier Mahon
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Novartis
Other Relationship - Bristol-Myers Squibb; Novartis